# Dover Corporation (DOV)

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-13  
**Report type:** Primer (steps 1–3 of 19)  
**API endpoint:** GET /api/v1/research/DOV/primer

## Business Model

---
ticker: DOV
step: 01
generated: 2026-05-12
source: quick-research
---

### Dover Corporation (DOV) — Business Overview

#### Business Description
Dover Corporation is a diversified global manufacturer and solutions provider operating across five segments in niche industrial end markets. Founded in 1955, Dover has compounded earnings per share at high single-digit rates for decades through a combination of organic growth, acquisitions, and operational execution. The company's strategy centers on leadership positions in growing niche markets where customers value engineering precision, reliability, and long-term supplier relationships over commodity pricing. In 2024, Dover sold its Environmental Solutions Group (refuse collection vehicles, street sweepers) for $2B, simplifying the portfolio and returning capital to shareholders. Dover is headquartered in Downers Grove, Illinois.

#### Revenue Model
Dover generates revenue through five operating segments: (1) **Engineered Products** (~22% of revenue): industrial automation components, vehicle service equipment, waste management equipment — diversified high-margin manufacturing; (2) **Clean Energy & Fueling** (~23%): fuel dispensing equipment, cryogenic components for LNG/hydrogen, CO2 refrigeration — exposure to energy transition; (3) **Imaging & Identification** (~15%): marking and coding systems, digital printing equipment, product traceability/brand protection software — high aftermarket/consumables mix; (4) **Pumps & Process Solutions** (~22%): precision pumps, flow measurement, biopharma single-use components — strong secular growth; (5) **Climate & Sustainability Technologies** (~18%): CO2 refrigeration systems (Advansor), heat pumps, food retail thermal management — regulatory-driven European demand.

#### Products & Services
- **Engineered Products**: CPC industrial connectors, Destaco automation products, MS Powder Solutions
- **Clean Energy & Fueling**: Wayne Fueling dispensing equipment, OPW fuel systems, cryogenic LNG/hydrogen components (built via 6 acquisitions 2021-2024)
- **Imaging & Identification**: Markem-Imaje marking and coding, Datasmart brand protection, product traceability software
- **Pumps & Process Solutions**: PSG pumps (Wilden diaphragm, Blackmer sliding vane, Almatec), ProMinent dosing, biopharmaceutical single-use components
- **Climate & Sustainability Technologies**: Advansor CO2 refrigeration (#1 in Europe), Anthony refrigeration doors, Unified Brands food equipment

#### Customer Base & Go-to-Market
Dover sells to industrial, commercial, and government customers globally through direct sales forces, distributors, and OEM channels. The aftermarket/service revenue component (~30–40% of some segments) provides revenue stability through cycles. Key verticals: food retail refrigeration, biopharma manufacturing, fuel/energy infrastructure, industrial automation, food & beverage processing. No single customer concentration. Geographic mix: ~55% North America, ~35% Europe, ~10% Asia-Pacific.

#### Competitive Position
Dover's competitive advantage is a portfolio of #1 or #2 market positions in niche markets where switching costs are high and relationships are long-term. The Pumps & Process Solutions segment (PSG) is the world's largest industrial pump company by volume; Markem-Imaje is one of the top two global marking/coding companies; Advansor is the European market leader in CO2 refrigeration. Dover's decentralized operating model allows each business to move with entrepreneurial speed while benefiting from Dover's scale in procurement, talent, and financial strength.

#### Key Facts
- Founded: 1955
- Headquarters: Downers Grove, Illinois
- Employees: ~24,000
- Exchange: NYSE
- Sector / Industry: Industrials / Industrial Machinery & Supplies
- Market Cap: ~$18–22B
- S&P 500 Dividend Aristocrat: 69+ consecutive years of dividend increases

## Financial Snapshot

---
ticker: DOV
step: 04
generated: 2026-05-12
source: quick-research
---

### Dover Corporation (DOV) — Financial Snapshot

#### Income Statement Summary

| Metric | FY2022 | FY2023 | FY2024 | YoY |
|--------|--------|--------|--------|-----|
| Revenue | ~$7.86B | $7.68B | $7.75B | +1% |
| Gross Margin | ~37% | ~37% | ~37% | flat |
| Operating Margin (adj.) | ~20% | ~20% | ~20% | flat |
| Net Income (GAAP) | ~$1.1B | ~$1.1B | ~$2.1B* | |
| Adj. EPS | ~$7.42 | $7.52 | $8.29 | +10% |

*FY2024 GAAP net income elevated by ~$1B gain from $2B sale of Environmental Solutions Group (closed Oct 2024). GAAP EPS from continuing ops was $10.09; adjusted EPS (excluding gain) was $8.29.*

*FY2026 guidance: Adj. EPS $8.95–$9.15 on revenue growth of 5–7%. Annualized adj. EPS 3-year CAGR was ~5% (FY2022–FY2024); management targets mid-to-high single-digit growth.*

#### Cash Flow & Balance Sheet (FY2024)

| Metric | Value |
|--------|-------|
| Operating Cash Flow | ~$1.2B |
| Free Cash Flow | ~$1.0B |
| FCF Margin | ~13% |
| Cash & Equivalents | ~$1.5B (elevated post-ESG sale) |
| Total Debt | ~$3.5B |
| Net Debt | ~$2.0B (net debt, declining) |
| Completed Buyback | $1.04B in FY2024, retiring ~3.9% of shares |

#### Key Ratios (approximate, FY2024)
- P/E (adj.): ~18–22x | FCF Yield: ~5%
- EV/EBITDA: ~14–16x | Dividend Yield: ~1.5%
- Revenue Growth (FY2024): +1% | FCF Margin: ~13%
- ROIC: ~15–18% | 3-year adj. EPS CAGR: ~5%

#### Growth Profile
Dover is a serial acquirer and compounder — it acquires niche industrial businesses, improves margins through the Dover Management System (DMS), then grows organically. Revenue growth is typically 2–6% organic + bolt-on acquisitions. FY2023–2024 were below-trend years: post-pandemic inventory destocking hit the Clean Energy & Fueling and Climate & Sustainability segments hard. FY2024 adj. EPS growth of 10% was helped by ESG sale proceeds and buybacks. FY2025 is expected to be a recovery year as destocking cycles in biopharma single-use components and CO2 refrigeration normalize; FY2026 guidance of 5–7% revenue growth implies a more normalized growth rate.

#### Forward Estimates
- **FY2025**: Revenue recovery expected; adj. EPS ~$8.50–$8.80 (transitional year post-ESG)
- **FY2026**: Adj. EPS $8.95–$9.15 (management guidance); revenue growth 5–7%; margins recovering toward 21%+
- **Capital allocation**: Dividend growth (69+ years), bolt-on M&A (~$500–800M/year), buybacks when valuation attractive; $1.04B completed in FY2024
- **Dividend**: $2.16/share annualized (~1.5% yield); S&P 500 Dividend Aristocrat

## Recent Catalysts

---
ticker: DOV
step: 12
generated: 2026-05-12
source: quick-research
---

### Dover Corporation (DOV) — Investment Catalysts & Risks

#### Bull Case Drivers

1. **Biopharma and Single-Use Component Recovery as a Cyclical Catalyst** — Dover's Pumps & Process Solutions segment, which includes precision pumps and biopharmaceutical single-use components (used in drug manufacturing, vaccine production, and cell therapy), was significantly impacted by post-pandemic inventory destocking in 2023–2024. Biopharma manufacturers over-built inventory of single-use bioreactor bags, filtration membranes, and fluid handling components during COVID-era supply chain anxiety, then sharply cut orders. As inventory normalization completes, Dover's biopharma exposure should snap back sharply — this segment can grow 15–20% in a recovery year. With FY2026 guidance of 5–7% organic growth already embedding some recovery, the upside case is biopharma growing significantly faster than guidance.

2. **Energy Transition Exposure Across Multiple Segments** — Dover has strategically built leading positions in several energy transition verticals: (a) Clean Energy & Fueling made six acquisitions to build a cryogenic components platform for LNG and hydrogen fueling infrastructure; (b) Climate & Sustainability Technologies' Advansor is the European market leader in CO2-based natural refrigeration systems (mandated by EU F-gas regulations that are phasing out HFC refrigerants); (c) Heat pumps and sustainable HVAC. As the EU's F-gas phase-out drives mandatory replacement of HFC refrigerant systems with CO2-based alternatives, Advansor's European order book should compound at double-digit rates. This regulatory-driven demand is highly predictable and margin-accretive.

3. **Portfolio Simplification and Capital Allocation Inflection** — The $2B sale of Environmental Solutions Group (refuse trucks, street sweepers) in 2024 eliminated Dover's lowest-margin, most capital-intensive segment and generated cash for redeployment. The completed $1.04B buyback (3.9% of shares) demonstrated capital discipline at a below-intrinsic-value price. With a clean balance sheet (~$2B net debt), $1B+ in annual FCF, and a proven M&A playbook, Dover is well-positioned to deploy capital into higher-return acquisitions in biopharma, precision pumps, and energy transition while maintaining dividend growth (69+ consecutive years). Management's confidence in the 2026 EPS outlook and buyback execution has improved market sentiment.

#### Bear Case Risks

1. **Persistent Margin Compression Across Multiple Segments** — Dover's net profit margin declined from 18% to 14% in FY2024 despite reported EPS being elevated by the ESG gain. The underlying margin compression reflects ongoing challenges: Clean Energy & Fueling segment faced slower-than-expected hydrogen fueling infrastructure build-out; Imaging & Identification segment saw reduced equipment orders as customers shifted to aftermarket-only mode; Engineered Products faced softness in vehicle service and industrial automation. If macro conditions deteriorate (manufacturing recession, trade disruption), multiple Dover segments could see simultaneous volume declines, and the decentralized management model may not respond quickly enough to prevent earnings disappointment.

2. **Cyclical Exposure to Industrial and Manufacturing Activity** — Dover's revenue is significantly exposed to capital spending decisions by industrial manufacturers, automotive service chains, food retailers, and energy companies — all of which are cyclically sensitive. In the 2015–2016 industrial recession, Dover's revenue declined ~4% and EPS fell sharply. In 2023, revenue declined 2% on destocking. With tariffs threatening to slow U.S. manufacturing activity and a potential economic slowdown on the horizon, Dover faces the risk of demand softness across several segments simultaneously. The portfolio is more diversified than most industrials, but not immune to a broad manufacturing downturn.

3. **M&A Execution and Integration Risk** — Dover made 8 acquisitions in FY2024 for $674M and has historically been an active acquirer. At the current valuation (~14–16x EV/EBITDA), M&A at reasonable prices is becoming harder to source — quality niche industrial businesses are expensive. If Dover overpays for acquisitions, overestimates synergies, or encounters integration challenges, goodwill impairments and EPS dilution could follow. The cryogenic components platform (built through 6 acquisitions for LNG/hydrogen) was predicated on hydrogen fueling infrastructure scaling faster than it has — if hydrogen adoption delays continue, this investment thesis underdelivers.

#### Upcoming Events
- **Q2 2026 Earnings (July 2026)**: Organic revenue growth vs. 5–7% guidance; biopharma recovery confirmation; Advansor CO2 order book update
- **FY2026 full year results**: Confirmation of adj. EPS $8.95–$9.15 target
- **Acquisition announcements**: Dover's M&A pipeline is a regular catalyst — any deal announcement signals management confidence in capital allocation
- **EU F-gas regulation implementation**: Accelerating ban on HFC refrigerants is a multi-year Advansor catalyst
- **Hydrogen fueling infrastructure pace**: A catalyst for the cryogenic components platform; currently below original expectations

#### Analyst Sentiment
Constructive: 62% Buy consensus; median price target ~$226. Bulls see recovery in biopharma/single-use, Advansor growth, and portfolio simplification as re-rating catalysts; bears cite the 14% net margin decline and uneven organic growth as concerns that the current 18–22x P/E may not be defensible if growth slows. Dover is widely regarded as a "compounder" with a proven track record, but near-term execution must confirm the recovery trajectory.

#### Research Date
Generated: 2026-05-12

## Full Research Available

This primer covers steps 1–3 of 19. The full deep dive (moat analysis, DCF, bull/bear,
management quality, earnings transcript analysis) is available via:

- Investment memo: /memo/dov
- Full research API: GET /api/v1/research/DOV/memo
- Coverage universe: /stocks